Finance

Beta
Lists
4896:TYO
K Pharma Inc
¥680.00
-1.16%
(-8.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4896...
Open
¥679
High
¥685
Low
¥650
Mkt. cap
7.90B
Avg. vol.
28.03K
Volume
41.90K
52-wk high
¥949
52-wk low
¥604
EPS
-¥90
No. of employees
20
Open
¥679
High
¥685
Low
¥650
Mkt. cap
7.90B
Avg. vol.
28.03K
Volume
41.90K
52-wk high
¥949
52-wk low
¥604
EPS
-¥90
No. of employees
20
News stories
From sources across the web
About K Pharma Inc
CEO-
Employees20
FoundedNov 1, 2016
Headquarters-
SectorPharmaceutical industry
Websitekpharma.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
414.00M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
239.00M
231.00M
-186.00M
237.00M
Operating expense
239.00M
231.00M
248.00M
237.00M
Total operating expenses
239.00M
231.00M
248.00M
237.00M
Operating income
-239.00M
-231.00M
-248.00M
-237.00M
Other non operating income
1.00M
-
-1.00M
-1.00M
EBT including unusual items
-244.00M
-236.00M
-312.00M
-250.00M
EBT excluding unusual items
-238.00M
-229.00M
-256.00M
-243.00M
Income tax expense
1.00M
1.00M
-
-
Effective tax rate
-0.41%
-0.42%
-
-
Other operating expenses
-
-
20.00M
-
Net income
-245.00M
-237.00M
-312.00M
-250.00M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
2.00M
-
2.00M
Interest expense
-
-
-7.00M
-7.00M
Net interest expenses
-
2.00M
-7.00M
-5.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer